Ameriprise Financial (AMP)
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
$560.56-0.80%
Close 2026-09-04 · 1-day change
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
QuarterlyIQ Insights · AMP
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $561 AMP trades at 13× p/e, below its 16× p/e peer median, but our blended $510 fair value sits below the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $489–$645. Even valued only for durable growth at sustainable margins, it's worth about $600 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $578.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $224.60 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $264.70 | — | — | Hist. CAGR | high |
| graham number | 12M | $257.57 | — | — | TTM | high |
| Peer P/B | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$489.00 – $645.00 (median $578.00) · 4 analysts · as of 2026-08-21
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $132.36 |
| 1.9 |
| 68.53 |
| TTM |
| high |
| Peer P/FCF | 12M | $372.63 | 13.5 | 27.56 | TTM | high |
| Peer P/E | 12M | $659.49 | 13.2 | 49.99 | ntm analyst | high |
| Peer P/S | 12M | $693.30 | 3.2 | 213.55 | TTM | high |
| PEG | 12M | $1112.68 | 25.9 | 43.03 | TTM | high |
| residual income | 12M | $204.25 | — | — | TTM | high |
| Own P/E history | 12M | $542.97 | 12.6 | 43.03 | TTM | high |
| triangulated | 12M | $710.80 | 16.3 | 43.48 | Triangulated | high |
| Peer P/B | 3Y | $201.30 | 1.9 | 104.22 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $237.06 | 13.5 | 17.53 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $737.05 | 13.2 | 55.87 | Analyst | medium |
| Peer P/S | 3Y | $795.27 | 3.2 | 244.96 | Analyst | medium |
| PEG | 3Y | $1444.68 | 25.9 | 55.87 | Analyst | medium |
| Own P/E history | 3Y | $704.98 | 12.6 | 55.87 | Analyst | medium |
| Peer P/B | 5Y | $266.21 | 1.9 | 137.83 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $175.35 | 13.5 | 12.97 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $805.89 | 13.2 | 61.09 | Analyst | high |
| Peer P/S | 5Y | $869.55 | 3.2 | 267.84 | Analyst | high |
| PEG | 5Y | $1579.62 | 25.9 | 61.09 | Analyst | high |
| Own P/E history | 5Y | $770.83 | 12.6 | 61.09 | Analyst | high |